ArticleAmerican journal of industrial medicine2019
Pneumococcal vaccination for welders: Global deployment within a multi-national corporation.
Article in American journal of industrial medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2023Guideline
- Review
- Vaccinating Welders against Pneumococcus: Evidence from a Systematic Review and Meta-Analysis.Vaccines · 2023Review
- Characteristics of immunisation support programmes in Canada: a scoping review and environmental scan.BMJ open · 2023Article
- Employee Participation in Workplace Vaccination Campaigns: A Systematic Review and Meta-Analysis.Vaccines · 2022Review
- Welder's Anthrax: A Review of an Occupational Disease.Pathogens (Basel, Switzerland) · 2022Review
- Article
- Occupational Respiratory Infections.Clinics in chest medicine · 2020Review
- Pneumococcal vaccination for welders: Global deployment within a multi-national corporation.American journal of industrial medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundLobar pneumonia is an occupational disease of welders. This is the first report of global deployment of a pneumococcal vaccination program for welders within a multi-national corporation.
methodsGlobal webinars were conducted to introduce the program. Communication packages translated into all location languages were deployed. All employee welders who had not previously been vaccinated were offered a free single dose of pneumococcal polysaccharide vaccine (PPV23) by on-site location medical centers during normal working hours. Numbers of vaccinated welders were reported by each location each month.
resultsTwelve months after starting the program, 241 of 767 welders have been vaccinated (31%) across six countries.
conclusionsGlobal deployment of pneumococcal vaccination for welders can be successfully undertaken by a multi-national corporation. Adoption of this practice by corporations could reduce the incidence and mortality of pneumonia among welders globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.